Annora Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANNORA, and what generic and branded alternatives to ANNORA drugs are available?
ANNORA has thirty-seven approved drugs.
There are five tentative approvals on ANNORA drugs.
Drugs and US Patents for Annora
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annora | DROXIDOPA | droxidopa | CAPSULE;ORAL | 211726-001 | Feb 18, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Annora | APREMILAST | apremilast | TABLET;ORAL | 211878-002 | Jul 26, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Annora Pharma | FAMOTIDINE | famotidine | TABLET;ORAL | 215767-002 | Nov 4, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Annora Pharma | POLYETHYLENE GLYCOL 3350 | polyethylene glycol 3350 | FOR SOLUTION;ORAL | 214990-001 | Apr 14, 2021 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Annora Pharma | FAMOTIDINE | famotidine | TABLET;ORAL | 215766-002 | Nov 8, 2021 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Annora Pharma | DIATRIZOATE MEGLUMINE AND DIATRIZOATE SODIUM | diatrizoate meglumine; diatrizoate sodium | SOLUTION;ORAL, RECTAL | 215049-001 | Nov 17, 2023 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Annora Pharma | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 216800-003 | May 31, 2023 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.